Fexofenadine-induced urticaria
Related Experiment Video
Updated: May 24, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Sang Woo Lee1, Ji Yeon Byun, You Won Choi
1Department of Dermatology, School of Medicine, Ewha Womans University, Seoul, Korea.
Abstract:
Fexofenadine (Allegra® 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Allergic Reactions
Allergic Reactions: Anaphylaxis
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Hypersensitivity Reactions: Immune-Complex Reactions
Allergic Drug Reactions